Inovio Pharmaceuticals, Inc. (INO)
1.26
-0.04
(-3.08%)
USD |
NASDAQ |
Aug 27, 16:00
1.27
+0.01
(+0.79%)
After-Hours: 05:52
Inovio Pharmaceuticals EPS Diluted (TTM) : -1.176 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.176 |
| March 31, 2026 | -1.708 |
| December 31, 2025 | -1.933 |
| September 30, 2025 | -2.585 |
| June 30, 2025 | -2.607 |
| March 31, 2025 | -3.187 |
| December 31, 2024 | -3.985 |
| September 30, 2024 | -4.485 |
| June 30, 2024 | -5.106 |
| March 31, 2024 | -5.534 |
| December 31, 2023 | -6.113 |
| September 30, 2023 | -7.562 |
| June 30, 2023 | -7.865 |
| March 31, 2023 | -11.79 |
| December 31, 2022 | -14.23 |
| September 30, 2022 | -17.69 |
| June 30, 2022 | -19.30 |
| March 31, 2022 | -18.47 |
| December 31, 2021 | -17.36 |
| September 30, 2021 | -12.92 |
| June 30, 2021 | -8.172 |
| March 31, 2021 | -13.38 |
| December 31, 2020 | -13.29 |
| September 30, 2020 | -16.29 |
| June 30, 2020 | -20.56 |
| Date | Value |
|---|---|
| March 31, 2020 | -14.24 |
| December 31, 2019 | -14.70 |
| September 30, 2019 | -14.31 |
| June 30, 2019 | -14.61 |
| March 31, 2019 | -11.97 |
| December 31, 2018 | -12.67 |
| September 30, 2018 | -11.38 |
| June 30, 2018 | -12.81 |
| March 31, 2018 | -13.41 |
| December 31, 2017 | -12.84 |
| September 30, 2017 | -14.21 |
| June 30, 2017 | -12.89 |
| March 31, 2017 | -14.45 |
| December 31, 2016 | -12.05 |
| September 30, 2016 | -10.80 |
| June 30, 2016 | -6.60 |
| March 31, 2016 | -4.56 |
| December 31, 2015 | -5.40 |
| September 30, 2015 | -3.84 |
| June 30, 2015 | -6.12 |
| March 31, 2015 | -7.165 |
| December 31, 2014 | -7.405 |
| September 30, 2014 | -9.325 |
| June 30, 2014 | -15.57 |
| March 31, 2014 | -16.32 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Fortress Biotech, Inc. | 2.657 |
| Tonix Pharmaceuticals Holding Corp. | -12.93 |
| Kura Oncology, Inc. | -3.362 |
| Spero Therapeutics, Inc. | 0.1091 |
| ACADIA Pharmaceuticals, Inc. | 2.220 |